Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/10/24 17:35 | 7/8/24 | MORF | Health | Drug | Pharmaceutical Preparations | Rogers Bruce | MA | O | P | 2 | S.d | -1,289 | 49.00 | 0 | -26 | 150 | D | |||||||||||||||
7/10/24 17:34 | 7/8/24 | MORF | Health | Drug | Pharmaceutical Preparations | Schegerin Marc | MA | O | CFO,COO | 2 | S.d | -2,618 | 52.38 | 0 | -50 | 38 | D | |||||||||||||||
7/10/24 17:33 | 7/8/24 | MORF | Health | Drug | Pharmaceutical Preparations | Tipirneni Praveen P. | MA | DO | CEO | 2 | S.d | -1,587 | 44.69 | 0 | -36 | 42 | D | |||||||||||||||
7/10/24 17:33 | 7/8/24 | MORF | Health | Drug | Pharmaceutical Preparations | Farrell Robert E Jr | MA | O | SVP Fina | 2 | S.d | -1,829 | 51.73 | 0 | -35 | 35 | D | |||||||||||||||
7/10/24 17:32 | 7/8/24 | MORF | Health | Drug | Pharmaceutical Preparations | Devaul William | MA | O | GC,Secre | 2 | S.d | -682 | 47.00 | 0 | -15 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |